These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23241526)

  • 61. Tumor dormancy and frailty models: A novel approach.
    Rancoita PM; Valberg M; Demicheli R; Biganzoli E; Di Serio C
    Biometrics; 2017 Mar; 73(1):260-270. PubMed ID: 27398936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determining the Factors Affecting Long-Term and Short-Term Survival of Breast Cancer Patients in Rafsanjan Using a Mixture Cure Model.
    Jahani S; Hoseini M; Pourhamid R; Askari M; Moslemi A
    J Res Health Sci; 2021 May; 21(2):e00516. PubMed ID: 34465639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Family history of the cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models.
    Ghadimi M; Mahmoodi M; Mohammad K; Zeraati H; Rasouli M; Sheikhfathollahi M
    BMC Gastroenterol; 2011 Oct; 11():104. PubMed ID: 21961837
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prediction the survival of patients with breast cancer using random survival forests for competing risks.
    Najafi-Vosough R; Faradmal J; Tapak L; Alafchi B; Najafi-Ghobadi K; Mohammadi T
    J Prev Med Hyg; 2022 Jun; 63(2):E298-E303. PubMed ID: 35968067
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk Prediction of One-Year Mortality in Patients with Cardiac Arrhythmias Using Random Survival Forest.
    Miao F; Cai YP; Zhang YX; Li Y; Zhang YT
    Comput Math Methods Med; 2015; 2015():303250. PubMed ID: 26379761
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Frailties in multi-state models: Are they identifiable? Do we need them?
    Putter H; van Houwelingen HC
    Stat Methods Med Res; 2015 Dec; 24(6):675-92. PubMed ID: 22116343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Application of additive hazards models for analyzing survival of breast cancer patients.
    Ataee Dizaji P; Vasheghani Farahani M; Sheikhaliyan A; Biglarian A
    J Res Med Sci; 2020; 25():99. PubMed ID: 33273944
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Spatial Survival Model in Presence of Competing Risks for Iranian Gastrointestinal Cancer Patients.
    Hesam S; Mahmoudi M; Rahimi Foroushani A; Yaseri M; Mansournia MA
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2947-2954. PubMed ID: 30362330
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of frailty in survival analysis.
    Aalen OO
    Stat Methods Med Res; 1994; 3(3):227-43. PubMed ID: 7820293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The assessment of risk factors and risk perception status of breast cancer in Northern Iran.
    Faryabi R; Daneshi S; Davarani ER; Yusefi AR; Arabpour M; Ezoji K; Movahed E; Daneshi-Maskooni M; Hussaini SM
    BMC Womens Health; 2023 May; 23(1):268. PubMed ID: 37194061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regression standardization and attributable fraction estimation with between-within frailty models for clustered survival data.
    Dahlqwist E; Pawitan Y; Sjölander A
    Stat Methods Med Res; 2019 Feb; 28(2):462-485. PubMed ID: 28901198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-Term Disease-Free Survival of Non-Metastatic Breast Cancer Patients in Iran: A Survival Model with Competing Risks Taking Cure Fraction and Frailty into Account.
    Ghavami V; Mahmoudi M; Rahimi Foroushani A; Baghishani H; Homaei Shandiz F; Yaseri M
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2825-2832. PubMed ID: 29072428
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of the fitness of Cox and parametric regression models of survival distribution for Iranian breast cancer patients' data.
    Mohseny M; Shekarriz-Foumani R; Amiri P; Vejdani M; Farshidmehr P; Mahmoudabadi HZ; Amanpour F; Mohaghegh P; Tajdini F; Sayarifard A; Davoudi-Monfared E
    J Adv Pharm Technol Res; 2019; 10(1):39-44. PubMed ID: 30815387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Age at diagnosis and the choice of survival analysis methods in cancer epidemiology.
    Cheung YB; Gao F; Khoo KS
    J Clin Epidemiol; 2003 Jan; 56(1):38-43. PubMed ID: 12589868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Explained variation in shared frailty models.
    Gleiss A; Gnant M; Schemper M
    Stat Med; 2018 Apr; 37(9):1482-1490. PubMed ID: 29282754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Application of Multi-State Model in Analyzing of Breast Cancer Data.
    Vasheghani Farahani M; Ataee Dizaji P; Rashidi H; Mokarian F; Biglarian A
    J Res Health Sci; 2020 Jan; 19(4):e00465. PubMed ID: 32291364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Small sample bias in the gamma frailty model for univariate survival.
    Barker P; Henderson R
    Lifetime Data Anal; 2005 Jun; 11(2):265-84. PubMed ID: 15938549
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparative study on splitting criteria of a survival tree based on the Cox proportional model.
    Shimokawa A; Kawasaki Y; Miyaoka E
    J Biopharm Stat; 2016; 26(2):386-401. PubMed ID: 26043356
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multivariate statistical analysis for anatomic pathology. Part II: failure time analysis.
    Vollmer RT
    Am J Clin Pathol; 1996 Oct; 106(4):522-34. PubMed ID: 8853043
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Frailty models for survival data.
    Hougaard P
    Lifetime Data Anal; 1995; 1(3):255-73. PubMed ID: 9385105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.